2-selenocyanato-N-((4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)sulfonyl)acetamide

ID: ALA5207489

PubChem CID: 168297240

Max Phase: Preclinical

Molecular Formula: C20H15F3N4O3SSe

Molecular Weight: 527.39

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(=O)(=O)NC(=O)C[Se]C#N)cc2)cc1

Standard InChI:  InChI=1S/C20H15F3N4O3SSe/c1-13-2-4-14(5-3-13)17-10-18(20(21,22)23)25-27(17)15-6-8-16(9-7-15)31(29,30)26-19(28)11-32-12-24/h2-10H,11H2,1H3,(H,26,28)

Standard InChI Key:  GBKXRWMODKATGS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   -0.6903    0.3163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1026    1.0309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6908    1.7427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1344    1.7427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5461    1.0326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1381    0.3163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3713    1.0326    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.7839    1.7473    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6091    1.7473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3713    0.2059    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0855    0.6193    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0217    2.4619    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0217    1.0326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8469    1.0326    0.0000 Se  0  0  0  0  0  2  0  0  0  0  0  0
   -1.9279    1.0309    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3404    0.3162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1619    0.5016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2428    1.3031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4829    1.6352    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9574    1.7157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6721    1.3031    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9574    2.5409    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6721    2.1283    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9278   -0.3983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1026   -0.3986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6919   -1.1114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1046   -1.8263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9257   -1.8279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3422   -1.1160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6920   -2.5409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2595    0.3180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6721   -0.3965    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
  7 11  2  0
  9 12  2  0
  9 13  1  0
 13 14  1  0
  2 15  1  0
 16 15  1  0
 16 17  2  0
 17 18  1  0
 19 18  2  0
 15 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
 16 24  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 28 27  1  0
 29 28  2  0
 24 29  1  0
 27 30  1  0
 14 31  1  0
 31 32  3  0
M  END

Alternative Forms

  1. Parent:

    ALA5207489

    ---

Associated Targets(Human)

NALM-6 (592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 527.39Molecular Weight (Monoisotopic): 527.9982AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Liu J, Zhang L, Guo L, Zeng Y, Guo Q, Yang C, Shu J, Liu W, Yang L..  (2022)  Novel bioactive hybrid Celecoxib-HDAC Inhibitor, induces apoptosis in human acute lymphoblastic leukemia cells.,  75  [PMID:36395680] [10.1016/j.bmc.2022.117085]

Source